When was Suleshvari Pharma founded?

Suleshvari Pharma was founded in 2004.

Where is Suleshvari Pharma located?

Suleshvari Pharma is headquartered in Ankleshwar, India.

Is Suleshvari Pharma a funded company?

Suleshvari Pharma is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Suleshvari Pharma rank among its competitors?

Suleshvari Pharma ranks 143rd amongst 146 active competitors, of which 9 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Inventys, which secured $29.5M in Apr, 2022.

Who are the top competitors of Suleshvari Pharma?

Suleshvari Pharma's top competitors include Blue Jet Healthcare, Viyash and Vivimed Labs. Among them, Inventys secured the most recent funding round in April, 2022.

Suleshvari Pharma - 2026 Company Profile & Competitors

Suleshvari Pharma is an unfunded company based in Ankleshwar (India), founded in 2004. It operates as a CDMO focused on manufacturing pharmaceutical intermediates. Suleshvari Pharma has not raised any funding yet. The company has 146 active competitors, including 9 funded and 15 that have exited. Its top competitors include companies like Blue Jet Healthcare, Viyash and Vivimed Labs.

Key Metrics

Founded Year

2004

Location

Ankleshwar, India

Stage

Unfunded

Ranked

143^rd among 146 active competitors

Similar Companies

Blue Jet Healthcare & 159 more

View Suleshvari Pharma's full profile

Suleshvari Pharma has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Suleshvari Pharma include Blue Jet Healthcare, Viyash and Vivimed Labs. Here is the list of Top 10 competitors of Suleshvari Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Blue Jet Healthcare 1969, Mumbai (India), Public	CDMO focused on manufacturing, supplier, and development of intermediates & APIs	-	-	57/100
2nd	Viyash 2019, Hyderabad (India), Seed	CDMO focused on manufacturing of APIs & intermediates	$120M	The Carlyle Group, Pharminn Enterprise & 43 others	57/100
3rd	Vivimed Labs 1988, Hyderabad (India), Public	Manufacturer of APIs, formulations and specialty chemicals	-	IFC, Orbimed & 5 others	51/100
4th	Optimus 2004, Hyderabad (India), Acquired	Manufacturer of APIs, intermediates, and finished formulations	$11.5M	Unichem Labs, Twine Steel & 39 others	50/100
5th	Inventys 2005, Mumbai (India), Series A	Custom based manufacturer of actives, crop protection, advanced intermediates, and specialty chemicals	$30.2M	Multi Organics, Birewar Family Trust & 18 others	46/100
6th	Ami organics 2007, Surat (India), Public	Pharmaceutical company manufacturing active pharmaceutical ingredient (API) intermediates	-	Plutus Wealth Management	43/100
7th	Veranova 2022, Wayne (United States), Acquired	CDMO focused on manufacturing of APIs and intermideates	-	-	42/100
8th	Lofty Laboratories 2005, India, Unfunded	CDMO focused on manufacturing pharmaceutical intermediates	-	-	41/100
9th	Valence Labs 2021, Rajpura (India), Unfunded	Manufacturer of pharmaceutical API for forefront of chemical innovation	-	-	41/100
10th	Sionc Pharmaceuticals 2010, Visakhapatnam (India), Unfunded	CDMO focused on manufacturing of complex and niche active pharmaceutical ingredients	-	-	39/100
143rd	Suleshvari Pharma 2004, Ankleshwar (India), Unfunded	CDMO focused on manufacturing pharmaceutical intermediates	-	-	16/100